id,disease_progression_status,survival_status,clinical_response_rate_target_lasion,clinical_response_rate_non_target_lasion,clinical_response_rate_new_lasion,clinical_response_rate_result,radiological_response_rate_target_lasion,radiological_response_rate_non_target_lasion,radiological_response_rate_new_lasion,radiological_response_rate_result,pathological_response_rate_target_lasion,pathological_response_rate_non_target_lasion,pathological_response_rate_new_lasion,pathological_response_rate_result,time,registration_number,laterality,current_chemo_protocol,chemo_starting_date,chemo_cycle_no,chemo_detail,disease_progression_status_date,pfs,survival_status_date,overall_survival,clinical_response_rate_date,radiological_response_rate_date,pathological_response_rate_date,cancer_type,patient_id_id,patient_id_socio_economic_status_name,patient_id_unique_id,patient_id_name,patient_id_phone,patient_id_date_of_birth,patient_id_gender,patient_id_blood_group,patient_id_area,patient_id_police_station,patient_id_district,doctor_id_name,center_id_name,grade_name,line_of_treatment_name,diagnosis_disease_group_name,diagnosis_subgroup_diagnosis_disease_group_name,diagnosis_subgroup_name,diagnosis_primary_site_name,diagnosis_laterility_name,patient_id_socio_economic_status,grade,disease_progression_status_name,survival_status_name,clinical_response_rate_target_lasion_name,clinical_response_rate_non_target_lasion_name,clinical_response_rate_new_lasion_name,clinical_response_rate_result_name,radiological_response_rate_target_lasion_name,radiological_response_rate_non_target_lasion_name,radiological_response_rate_new_lasion_name,radiological_response_rate_result_name,diagnosis_laterility,line_of_treatment,diagnosis_subgroup,pathological_response_rate_target_lasion_name,pathological_response_rate_non_target_lasion_name,pathological_response_rate_new_lasion_name,pathological_response_rate_result_name,diagnosis_disease_group,diagnosis_primary_site,name,value,unit,date,patient_observation_id
157,,,,,,,,,,,,,,,2024-06-03T14:02:32+06:00,BSH - H12104159036,Left,Letrozole,2021-10-16,,"Started ADCT with AC, C1 started from 24.05.2021, Cycle 4 is completed on 27.06.21>
Cycle 8 with Paclitaxel completed on 20.09.2021> Started Oral Letrozole from 16.10.2021",2023-05-26,,2023-12-19,,2021-10-14,,2021-06-04,Breast,152,Upper middle class,BSBSC-240000152,SYEDA SHAHANA NAZNIN,1711321393,1958-06-15,Female,,,,,Dr Ferdous Ara Begum,BSH,2.0,Continuous Maintenance,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,C50.4- Upper-outer quadrant of breast,Breast,Left,,,Stable,Alive,CR,,,,,,,,,,,CR,,,,,,,,,,
552,,,,,,,,,,,,,,,2024-05-20T18:11:19+06:00,BSH - H12104159036,Left,,,,,,,,,,,,Breast,152,Upper middle class,BSBSC-240000152,SYEDA SHAHANA NAZNIN,1711321393,1958-06-15,Female,,,,,Dr Ferdous Ara Begum,BSH,2.0,,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,"C50.9- Breast, unspecified",Breast,Left,,,,,,,,,,,,,,,,,,,,,,,,,,
